Live Breaking News & Updates on Difei Yang Mizuho

Stay updated with breaking news from Difei yang mizuho. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript


FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
FibroGen Inc (NASDAQ: FGEN)
Operator
Good day, and welcome. Thank you for standing by. Welcome to the FibroGen First Quarter 2021 Financial Results Conference Call. [Operator Instructions] After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker for today, Mr. Michael Tung. Please go ahead.SPONSORED:
10 stocks we like better than FibroGen
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Michael Tung , Lisa Yang Goldman Sachs , Andy Hsieh , Jason Gerberry , Edwin Zhang , Annabel Samimy , Tricia Stewart , Christinel Chung , Annabel Samimy Stifel , Andy Hsieh William Blair , Percy Carter , Chris Chung , Elias Kouchakji , Enrique Conterno , Michael Yee , Yaron Werber , Difei Yang Mizuho , Michael Yee Jefferies , Pat Cotroneo , Paul Choi , Brendan Smith Cowen , Geoffrey Porges , Mark Eisner , Difei Yang , Fibrogen Inc ,

Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript


Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Nektar Therapeutics (NASDAQ: NKTR)
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Nektar Therapeutics Fourth Quarter 2020 Financial Results. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Jennifer Ruddock, Head of Corporate Affairs. Ma am, you may begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our ....

Brian Kotzin , Ben Burnett Stifel , Andy Hsieh , Gil Labrucherie , Eli Lilly , Jessica Fye , Howardw Robin , Andy Hsieh William Blair , Jay Olson Oppenheimer , Jonathan Zalevsky , Peter Lawson , Gilm Labrucherie , Jessica Fye Jpmorgan , Jay Olson , Brianl Kotzin , Ben Burnett , Difei Yang Mizuho , Paul Choi Goldman Sachs , Jennifer Ruddock , Paul Choi , Howard Robin , Steve Rosenberg , Peter Lawson Barclays , William Blair , Difei Yang , Nektar Therapeutics ,